CD163 and neoplasm: The large monocyte/macrophage tumour infiltrate is also altered by CHK1i+LDHU treatment, with downregulated expression of CD206 and CD163, markers of classically activated M2 macrophages, and increased expression of iNOS and Msr1, markers of alternatively activated M1 macrophages [50].